- Home
- LE vs PRQR Comparison
LE vs PRQR Comparison
Compare LE & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LE
- PRQR
- Stock Information
- Founded
- LE 1963
- PRQR 2012
- Country
- LE United States
- PRQR Netherlands
- Employees
- LE N/A
- PRQR N/A
- Industry
- LE Clothing/Shoe/Accessory Stores
- PRQR Biotechnology: Pharmaceutical Preparations
- Sector
- LE Consumer Discretionary
- PRQR Health Care
- Exchange
- LE Nasdaq
- PRQR Nasdaq
- Market Cap
- LE 274.7M
- PRQR 163.3M
- IPO Year
- LE N/A
- PRQR 2014
- Fundamental
- Price
- LE $8.42
- PRQR $1.66
- Analyst Decision
- LE Strong Buy
- PRQR Strong Buy
- Analyst Count
- LE 1
- PRQR 7
- Target Price
- LE $20.00
- PRQR $9.00
- AVG Volume (30 Days)
- LE 216.7K
- PRQR 470.6K
- Earning Date
- LE 06-05-2025
- PRQR 05-08-2025
- Dividend Yield
- LE N/A
- PRQR N/A
- EPS Growth
- LE N/A
- PRQR N/A
- EPS
- LE 0.20
- PRQR N/A
- Revenue
- LE $1,362,935,000.00
- PRQR $21,212,711.00
- Revenue This Year
- LE $4.26
- PRQR $2.87
- Revenue Next Year
- LE $2.67
- PRQR N/A
- P/E Ratio
- LE $42.16
- PRQR N/A
- Revenue Growth
- LE N/A
- PRQR 85.91
- 52 Week Low
- LE $7.65
- PRQR $1.07
- 52 Week High
- LE $19.88
- PRQR $4.62
- Technical
- Relative Strength Index (RSI)
- LE 43.03
- PRQR 52.16
- Support Level
- LE $8.52
- PRQR $1.66
- Resistance Level
- LE $9.15
- PRQR $1.83
- Average True Range (ATR)
- LE 0.39
- PRQR 0.10
- MACD
- LE 0.01
- PRQR -0.00
- Stochastic Oscillator
- LE 0.85
- PRQR 48.48
About LE Lands' End Inc.
Lands' End Inc is a United States-based multi-channel retailer of casual clothing, accessories, and footwear, as well as home products. The company's operating segment includes U.S. eCommerce; International; Outfitters; Third Party and Retail. It generates maximum revenue from the U.S. eCommerce segment. The U.S. eCommerce segment offers products through the company's eCommerce website. Geographically, it derives a majority of its revenue from the United States.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.